Introduction
Endometriosis, is disease in which the presence of endometrial
tissue in ectopic sites, other than uterine cavity and is one of the
commonest causes of female infertility 1. About 15% of peoples in
industrialized world is consults for infertility 2. The frequency of the
endometriosis in Pakistan reported to 20.2% in cases of primary
infertility3 which is consistence with results of other studies of
different populations4,5.
New evidence propose that possible role of envir onmental
contamination of endocrine disrupting chemicals (EDC’s) in the
pathophysiology of endometriosis 6. An endocrine disrupting
chemical is an exogenous substance that hinder with production,
binding, and removal of natural sex hormones 7. Some chemicals
stimulate the growth of endometrial cells that play an important role
in endometrial angiogenesis 8,9. Among such EDC’s phthalates
have attained special focus due to their existence in everyday life
products10.
Phthalates are esters of Phthalic acid. A class of organic chemicals
that are used as plasticizer to increase the pliability of
polyvinylchloride (PVC). They are used in immense range of
products for example food packaging materials, medical devices,
medicines, kids’ toys as well as beauty and personal care
brands11. Out of the primary phthalate compounds , diethyl
phthalate (DEP) is most frequently used plasticizer globally. Its
most common use is in cosmetics, pharmaceutical and food
packaging materials12.
Once in side the body these phthalates are promptly
metabolized to their monoesters after hydrolysis and conju gation,
and then excreted in urine, feces and other body secretions.
Primary and secondary phthalate metabolites are bio -active13,14.
Public and scientific concern is being focused to inquire the role of
phthalate exposure in estrogen related disease such as
endometriosis. Studies have shown accumulation of these
substances in blood, follicular fluid, urine, saliva and sweat of
infertile females 15,16,17. So far, fewer reports have been published
on the subject and nothing exists from Pakistan. A Few authors
reported that there is positive association between phthalate
-----------------------------------------------------------------------------------------
Received on 07-06-2021
Accepted on 27-11-2021
exposure and endometriosis 18,19, while others reported
contradictions20,21. Pakistan is a country where plastic and plastic
related products are very heavily used, particularly by the lower
middle class and modest communities. Plastic containers are even
used for carrying very hot food items and apart from their industrial
use, small factories or cottage industries making plastic utensils
and shopping bags use recycled plastic materials, which make
these items quite hazardous to t he general health of the public.
Also there are women of the reproductive age who work in these
home-based factories where there is least concept of quality
control, quality assurance and health hazards. Keeping in view of
these facts we conducted the present study to understand whether
exposure to diethyl phthalate is associa ted with risk of
endometriosis.
Material and methods
The case control study was approved by Ethical review board of
University. Sample size was calculated by using the following
formula:
Study population comprised of 50 young (20 -40 years) females
laparoscopically diagnosed of endometriosis and had a history of
infertility (>1 years). Staging of the disease was done according to
ASRM criteria for endometriosis staging 22. A comparable number
(n=50) of same age group healthy females who gave birth a child
in last two years, also negative for endometriosis screened by
ultrasonography followed by detailed clinical evaluation and
examination by specialized doctors served as controls. Females on
any medication especially hormone treatment, history of infertility
other tha n endometri osis or having co -morbid conditions , were
excluded from the study. After taking written well informed consent
from all study participants, a detailed medical, socioeconomic and
occupational history with detailed general physical and systemic
clinical evaluation was done by a qualified doctor.
Ten milliliters of blood was drawn under aseptic conditions.
Serum was separated after centrifugation; and stored in glass vials
at -80 ◦C for later analysis. High performance liquid
S. Nazir, I. Nazir, R. Khan et al
P J M H S Vol. 15, No.12, DEC 2021 3215
chromatography (Perkin Elmer series 200 UV pump) was used to
determine diethyl phthalate concentrations.
Reagents and solutions preparation : Stock solution of HPLC
grade (Merck chemicals, Germany) 99.99% diethyl phthalate
(DEP) and its internal standards were prepared in HPLC grade
(Fisher scientific, Germany) acetonitrile, and stored at -20˚C to test
the linearity. With a DEP concentration of 10, 50, 100, 250, 500,
and 1000 ng/ml, Calibrators were prepared in serum. A total of 200
µL of serum was added with 50 µL of internal standard, 400 µL of 1
mol/L NaOH (HPLC grade; Sigma Aldrich, USA), 100 µL of 50 %
H3PO4 (HPLC grade; Sigma Aldrich USA) and 600 µL of 50 %
acetonitrile (Fisher scientific, Germany).
High Performan ce Liquid Chromatography (HPLC): After 10
minutes at 1500 rpm centrifugation , the supernatant was
separated, and 10 µL of the supernatant was injected into the
HPLC glass vials via syringe filter (25mm/ 0.22 micrometer) , and
put in auto- sampler (Perkin Elmer series 200). To avoid potential
contamination, all glass vials were clean with methanol, acetone
and acetonitril. HPLC was carried out using Perkin Elmer series
200 UV pump, attached to a Diode Array UV/ visible Perkin Elmer
series 200 detector. A Perkin Elmer 250 x 4.6 mm (internal
diameter) Brownlee analytical C18 (5 -µm particle size) column
(USA) was used. Results were analyzed on Total chrome
Navigator 3.1.5 software. The mobile phase consisted of a mixture
of 1ml/L acetic acid (Sigma Aldrich, USA) in water and 1ml/L acetic
acid in acetonitrile (10/90, vol/vol). Elution was performed with the
use of an isocratic mode at 0.5 ml/min. Total chromatographic run
time was 10 minutes. Peak for DEP was obtained at 6.43 minutes
(retention time). Concentration of DEP was calculated by using
straight line equation.
Statistical analysis : By using IBM -SPSS version 20 , data was
analyzed. The variables were analyzed and expressed as
Mean(±SD). Two sample Student’s‘t’ test, was applied to compare
the phthalate esters concentrations in both cases and controls. A p
value of ≤ 0.05 was considered as statistically significant. To
compare the levels of DEP between different stages of
endometriosis one-way ANOVA was applied.
Discussion
Endometriosis is a gynecological disorder, which is characterized
by the existence of ectopic endometrial tissue. Regardless of th e
extensive development of endometriosis , the etiology and
pathophysiology of the disease is yet to be explicated.
Environmental hazardous toxins have previously shown to
be associated to endometriosis. The aim of this study was to
identify the levels of phthalates, which are comm on endocrine
disruptors, in age- matched females with diagnosed endometriosis,
as well as healthy females. Pakista n lacks a strict quality control
over the use of common plastic compounds such as plastic food
wraps, medical devices, beverages containers, and the linings of
metal cans. A good number of Pakistani females work in the
pharmaceutical industry and an equally good number uses daily
cosmetics. Hence, the risk of exposure to phthalates in this region
is reasonably higher compared to developed coun tries. Although a
variety of phthalate compounds has been studied, we selected
DEP which is a parent compound of phthalate, widely distributed
and mostly present in plastic, medical devices and daily use
products. It enter the body through inhalation, cutaneous contact,
and through food and medicine ingestion23.
The literature for serum DEP levels in infertile females with
endometriosis is sparse. This study is the first report from Pakistan
demonstrating the relationship between serum DEP levels and
infertility with endometriosis. Our study recruited endometriosis
patients diagnosed by laparoscopy. Our results showed
significantly higher (p=0.003) serum DEP (diethyl pht halate) levels
in females with endometriosis, compared to controls. These results
are i n accord with previous study , which shows high DEP levels
but detection rate is low in this study (0 -16.4%)24. This difference
may be due to more judicial use of DEP products in our country
especially hot food packaging in plastic bags and containers and
poor quality cosmetic products. These results are contrary to
previous studies which show undetectable levels of DEP in both
cases and controls 24-27. This difference in results may be due to
differences in the techniques, as Reddy et al (2003) used gas
chromatography and in Rozati et al (2008) (28) HPLC techniqu e,
control and cases criteria was different from ours. DEP used as a
solvent and fixative for fragrance , cosmetic ingredients ,
subsequent contact with skin may lead to high levels of DEP. In
order to show correlation between DEP concentrations and
severity of the disease, we analyzed the mean DEP values
between stages (I, II, III and IV) of endometriosis. This analysis
showed no significant diffe rence in mean DEP le vels among the
stages of endometriosis. However, there was an increasing trend
S. Nazir, I. Nazir, R. Khan et al
P J M H S Vol. 15, No.12, DEC 2021 3217
of mean values of DEP with advancement of stage (Table 1).
These results were in contrary to previous study24 which showed
increase phthalate levels with advancement of disease. We
compared the anthropometric parameters , i.e. age at menarche,
height, weight and age with serum DEP levels , but no statistical ly
significant difference was observed between cases and c ontrols
(Table 2). Therefore, no association was ascertained among the
anthropometric factors and endometriosis which is in consistency
with previous results by Rozati et al28.
Our results favor the previous studies showing positive
association of Diethyl phthalates with endometriosis. Unfortunately,
because of our financial limitations , we could not expand our
experiments, which may provide more elaborated understanding
about the possible role of these phthalate compounds in the
pathophysiology and etiology of endometriosis.
References
1. Parasar P, Ozcan P, Terry KL. Endometriosis: Epidemiology,
Diagnosis and Clinical Management. Curr Obstet Gynecol Rep. 2017;
6(1):34–41.
2. Reid, R., Steel, A., Wardle, J. et al. The prevalence of self -reported
diagnosed endometriosis in the Australian population: results from a
nationally-representative survey. BMC Res Notes, 2019; 12, 88.
3. Rao SI, Siddiq S, Qadir SY, Sarfraz Z, Ra na M. Endometriosis;
prevalence of endometriosis on laparoscopy in subfertile women.
Professional Med J 2019; 26(5):702-706.
4. Al-Jefout, M., Alnawaiseh, N., Yaghi, S., Alqaisi, A., Prevalence of
Endometriosis and Its Symptoms among Young Jordanian Women
with Chronic Pelvic Pain Refractory to Conventional Therapy. Journal
of Obstetrics and Gynaecology Canada, 2018; 40 (2), 165-170.
5. Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364(9447):1789–99
6. Smarr MM, Kannan K, Buck Louis GM. Endocrine disrupting chemicals
and endometriosis. Fertil Steril. 2016 Sep 15;106 (4): 959-66.
7. Diamanti-Kandarakis, E., Bourguignon, J.P., Giudice, L.C., Hauser, R.,
Prins, G.S., Soto, A.M., 2009. Review: Endocrine -disrupting
chemicals: an Endocrine Society Scientific Statement. Endocr. Rev.,
30(4): 293-342.
8. Bredhult C, Backlin BM, Olovsson M. Effects of some endocrine
disruptors on the proliferation and viability of human endometrial
endothelial cells in vitro. Reprod toxicol 2007, 23:550-9
9. Crain DA, Janssen SJ, Edwards TM, Heindel J, Ho SM, Hunt P, et al.
Female reproductive disorders: the roles of endocrine -disrupting
compounds and developmental timing. Ferti sterti 2008, 90; 911 -40
10. Witorsch RJ, Thomas JA. Personal care products and endocrine
disruption: A critical review of the literature. Crit Rev Toxicol. 2010; 40
Suppl 3:1-30.
11. Pasquale Ventrice, Domenica Ventrice, Emilio Russo, Giovambattista
De Sarro. Phthalates: European regulation, chemistry,
pharmacokinetic and related toxicity. Environmental Toxicology and
Pharmacology. 2013; 36 (1), 88-96.
12. Veiga, Marlei, Bohrer, Denise, Nasciment o, Paulo C., Ramirez, Adrian
G., Carvalho, Leandro M., & Binotto, Regina. Migration of phthalate -
based plasticizers from PVC and non -PVC containers and medical
devices. Journal of the Brazilian Chemical Society, 2012; 23(1), 72-77.
13. Elena Domínguez -Romero, Martin Scheringer. A review of phthalate
pharmacokinetics in human and rat: what factors drive phthalate
distribution and partitioning? Journal Drug Metabolism Reviews . 2019;
51 (3), 314-329
14. Choi J, Knudsen LE, Mizrak S, Joas A.. Identification of exposur e to
environmental chemicals in children and older adults using human
biomonitoring data sorted by age: results from a literature review.
2017. Int J Hyg Environ Health. 220:282–298.
15. G. Saravanabhavan, M Walker, M Guay, L Aylward. Urinary excretion
and dai ly intake rates of diethyl phthalate in the general Canadian
population. Science of the Total Environment . 2014; 500 –501, 191 –
198.
16. Drbohlav, P., Jirsová, S., Masata, J., Jech, L., Bencko, V., Omelka, M.,
Zvárová, J., 2005. Relationship between the levels of toxic
polychlorinated biphenyls in blood and follicular fluid of sterile
women. Ceska. Gynekol., 70(5): 377-383.
17. Jing Sun , Bo Chen , Liqian Zhang , Dong Zhao , Shu Guang
Li.Phthalate ester concentrations in blood serum, urine and
endometrial tissues of Chinese endometriosis patients. Int J Clin Exp
Med . 2016; 9(2): 3808-3819
18. Itoh, H., Iwasaki, M., Hanaoka, T., Sasaki, H., Tanaka, T., Tsugane,
S., Urinary phthalate monoesters and endometriosis in infertile
Japanese women. Sci.Total Enviro., 2009. 408(1): 37-42.
19. Kim, Y.H., Kim, S.H., Lee, H.W., Chae, H.D., Kim, C.H., Kang, B.M.,
Increasedviability of endometrial cells by in vitro treatment with di -
(2ethylhexyl) phthalate. Fertil. Steril., 2010. 94(6): 2413 -2416.
20. Pauwels, A., Schepens, P.J., D'Hoo ghe, T., Delbeke, L., Dhont, M.,
Brouwer, A., Weyler, J., 2001. The risk of endometriosis and
exposure to dioxins and polychlorinated biphenyls: a case -control
study of infertile women. Hum. Reprod., 16: 2050-2055.
21. Blount BC, Silva MJ, Caudill SP, et al. (2000). Levels of seven urinary
phthalate metabolites in a human reference population. Environ Health
Perspect, 108, 979–82
22. Neil P Johnson, Lone Hummelshoj, G David Adamson, Jörg
Keckstein, Hugh S Taylor, Mauricio S Abrao, Deborah Bush, Ludwig
Kiesel, Rulla Tamimi, Kathy L Sharpe -Timms, Luk Rombauts, Linda C
Giudice, World Endometriosis Society Sao Paulo Consortium, World
Endometriosis Society consensus on the classification of
endometriosis, Human Reproduction, 2017; 32(2), 315–324,
23. National Research Coun cil (US) Committee on the Health Risks of
Phthalates. Phthalates and Cumulative Risk Assessment: The Tasks
Ahead. Washington (DC): National Academies Press (US); 2008. 2,
Phthalate Exposure Assessment in Humans. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK215044/
24. Reddy, B.S., Rozati, R., Reddy, B.V., Raman, N.V., 2006a.
Association of phthalate esters with endometriosis in Indian women.
B.J.O.G., 113: 515–520.
25. Cobellis, L., Latini, G., DeFelice, C., Razzi, S., Paris, I., Ruggieri, F.,
Mazzeo, P., Petraglia, F., 2003. High plasma concentrations of di -(2-
ethylhexyl)-phthalate in women with endometriosis. Human Reprod.,
18:1512-1515.
26. Gerhard, I.; Daniel, V., Link, S., Monga, B., Runnebaum, B., 1998.
Chlorinated hydrocarbons in women with repeated misc arriages.
Environ. Health Perspect., 106(10): 675-681.
27. Itoh, H., Iwasaki, M., Hanaoka, T., Sasaki, H., Tanaka, T., Tsugane,
S., 2009. Urinary phthalate monoesters and endometriosis in infertile
Japanese women. Sci.TotalEnviro., 408(1): 37-42.
28. Rozati, R., Simha, B., Bendi, N., Sekhar, C., 2008. Evaluation of the
Phthalate Esters in South Indian Women with Endometriosis. I. J. F.
S., 1(4): 165-170.